Competitive situation analysis of RNA interference drugs based on patents
YUAN Ya-kun
XIAO Yu-feng
ZHANG Bin
Abstract：RNA interference(RNAi)technology holds broad application prospects in the biomedical field and has garnered extensive attention from researchers and biopharmaceutical enterprises.This paper reviews the developmental trajectory of RNAi technology and the patent landscape of marketed RNAi drugs.It further analyzes the trends in patent applications and grants,the countries or regions where patents are filed or accepted,the institutions involved in patent applications,and several major technical themes.The study reveals that the number of RNAi-related patent applications and grants is growing.The United States and China are identified as both primary sources of technological innovation and significant target markets.Overall,the United States exhibits superior patent quality and technological commercialization compared to China and other countries.Despite challenges in delivery systems and other aspects,RNAi drugs are expected to play a more critical role in the medical field in the future.As technology advances and the market expands,RNAi drugs will offer novel solutions to global health issues.
Keywords：nucleic acid drugsRNA interferencepatent analysiscompetitive situation
Publication Date：2026-01-30
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：13( 128-140 )